Walgreens Boots Alliance, Inc. (WBA)Â
Trading
Quantity
Profitability
Ownership
Largest Insider Buys in Sector
WBA Insider Trading Activity
WBA Median Price and Trade Amounts History Chart
Statistics of Insider Transactions
Amount of Insider Buys and Sells
Buys | $170,430 | 2 | 100 |
Sells | $0 | 0 | 0 |
Related Transactions
| Mahajan Manmohan | EVP and Global CFO | 1 | $116,280 | 0 | $0 | $116,280 |
| Bhandari Inderpal S | director | 1 | $54,150 | 0 | $0 | $54,150 |
About Walgreens Boots Alliance, Inc.
Walgreens Boots Alliance, Inc. operates as a pharmacy-led health and beauty retail company. It operates through two segments, the United States and International. The United States segment sells prescription drugs and an assortment of retail products, including health, wellness, beauty, personal care, consumable, and general merchandise products through its retail drugstores. It also provides central specialty pharmacy services and mail services. As of August 31, 2021, this segment operated 8,965 retail stores under the Walgreens and Duane Reade brands in the United States; and five specialty pharmacies. The International segment sells prescription drugs; and health and wellness, beauty, personal care, and other consumer products through its pharmacy-led health and beauty retail stores and optical practices, as well as through boots.com and an integrated mobile application. It also engages in pharmaceutical wholesaling and distribution business in Germany. As of August 31, 2021, this segment operated 4,031 retail stores under the Boots, Benavides, and Ahumada in the United Kingdom, Thailand, Norway, the Republic of Ireland, the Netherlands, Mexico, and Chile; and 548 optical practices, including 160 on a franchise basis. Walgreens Boots Alliance, Inc. was founded in 1901 and is based in Deerfield, Illinois.
Insider Activity of Walgreens Boots Alliance, Inc.
Over the last 12 months, insiders at Walgreens Boots Alliance, Inc. have bought $170,430 and sold $0 worth of Walgreens Boots Alliance, Inc. stock.
On average, over the past 5 years, insiders at Walgreens Boots Alliance, Inc. have bought $499,568 and sold $497,500 worth of stock each year.
Highest buying activity among insiders over the last 12 months: Mahajan Manmohan (EVP and Global CFO) — $116,280. Bhandari Inderpal S (director) — $54,150.
The last purchase of 3,000 shares for transaction amount of $54,150 was made by Bhandari Inderpal S (director) on 2024‑04‑11.
List of Insider Buy and Sell Transactions, Walgreens Boots Alliance, Inc.
| 2024-04-11 | Bhandari Inderpal S | director | 3,000 0.0003% | $18.05 | $54,150 | -38.76% | ||
| 2024-04-02 | Mahajan Manmohan | EVP and Global CFO | 6,000 0.0007% | $19.38 | $116,280 | -40.46% | ||
| 2024-01-29 | JARRETT VALERIE B | director | 4,456 0.0005% | $22.44 | $99,993 | -47.71% | ||
| 2024-01-16 | Sale | SCHLICHTING NANCY M | director | 15,209 0.0018% | $23.05 | $350,567 | -47.47% | |
| 2024-01-05 | WENTWORTH TIMOTHY C | Chief Executive Officer | 10,000 0.0011% | $24.22 | $242,220 | -51.58% | ||
| 2023-11-10 | Sale | Gates Richard P. | SVP, Chief Pharmacy Officer | 1,000 0.0001% | $20.45 | $20,450 | -13.52% | |
| 2023-06-30 | DRISCOLL JOHN PATRICK | EVP, Pres. U.S. Healthcare | 5,172 0.0006% | $28.42 | $146,984 | -21.47% | ||
| 2023-03-29 | BREWER ROSALIND G | CEO | 10,000 0.0012% | $33.95 | $339,510 | -24.83% | ||
| 2022-11-18 | Sale | Ban Kevin M. | EVP, Chief Medical Officer | 10,303 0.0012% | $40.19 | $414,108 | -18.44% | |
| 2022-11-17 | Sale | SCHLICHTING NANCY M | director | 16,570 0.0019% | $39.89 | $660,928 | -19.19% | |
| 2021-11-19 | Sale | SCHLICHTING NANCY M | director | 2,725 0.0003% | $47.16 | $128,497 | -6.92% | |
| 2020-11-11 | Sale | Pagni Marco Patrick Anthony | EVP, Global CAO and GC | 10,000 0.0012% | $41.55 | $415,450 | +21.49% | |
| 2019-11-05 | Sale | Pagni Marco Patrick Anthony | EVP, Global CAO and GC | 468,710 0.0543% | $63.16 | $29.6M | -28.46% | |
| 2019-08-15 | Sale | Pagni Marco Patrick Anthony | EVP, Global CAO and GC | 246,992 0.0272% | $50.06 | $12.36M | +3.21% | |
| 2019-08-14 | Sale | Pagni Marco Patrick Anthony | EVP, Global CAO and GC | 183,654 0.0202% | $51.03 | $9.37M | +0.93% | |
| 2019-05-09 | Sale | Pagni Marco Patrick Anthony | EVP, Global CAO and GC | 40,000 0.0044% | $53.05 | $2.12M | +0.57% | |
| 2019-04-03 | Barra Ornella | Co-Chief Operating Officer | 36,000 0.0039% | $54.56 | $1.96M | -0.93% | ||
| 2018-11-20 | Sale | SCHLICHTING NANCY M | director | 14,100 0.0015% | $78.81 | $1.11M | -29.63% | |
| 2018-11-01 | Sale | FOOTE WILLIAM C | director | 5,472 0.0006% | $79.48 | $434,915 | -29.34% | |
| 2018-11-01 | Sale | Scardino Kimberly R | SVP, Global Controller and CAO | 15,705 0.0017% | $79.79 | $1.25M | -29.34% |
Insider Historical Profitability
| Mahajan Manmohan | EVP and Global CFO | 166969 0.0193% | $1.85M | 1 | 0 | |
| Bhandari Inderpal S | director | 3000 0.0003% | $33,300.00 | 1 | 0 | |
| Pessina Stefano | Executive Vice Chairman, CEO | 144788821 16.7437% | $1.61B | 3 | 1 | +0.21% |
| Rosenstein Barry | director | 4579100 0.5295% | $50.83M | 0 | 6 | |
| Barra Ornella | Co-Chief Operating Officer | 1718000 0.1987% | $19.07M | 3 | 1 | +1.3% |
| Gourlay Alexander W. | EVP and President of Walgreens | 734389 0.0849% | $8.15M | 0 | 1 | |
| WENTWORTH TIMOTHY C | Chief Executive Officer | 585122 0.0677% | $6.49M | 1 | 0 | <0.0001% |
| Fairweather George Rollo | EVP and Global CFO | 513563 0.0594% | $5.7M | 0 | 1 | |
| BREWER ROSALIND G | CEO | 369945 0.0428% | $4.11M | 1 | 0 | <0.0001% |
| Gates Richard P. | SVP, Chief Pharmacy Officer | 73929 0.0085% | $820,611.90 | 0 | 1 | |
| DRISCOLL JOHN PATRICK | EVP, Pres. U.S. Healthcare | 59050 0.0068% | $655,455.00 | 1 | 0 | <0.0001% |
| Wilson-Thompson Kathleen | EVP and Global Chief HRO | 55676 0.0064% | $618,003.60 | 0 | 8 | |
| Lederer John Anthony | director | 50000 0.0058% | $555,000.00 | 4 | 0 | <0.0001% |
| SABATINO THOMAS J JR | EVP, Global CLO and CAO | 44536 0.0052% | $494,349.60 | 0 | 1 | |
| Pagni Marco Patrick Anthony | EVP, Global CAO and GC | 34700 0.004% | $385,170.00 | 0 | 5 | |
| Ban Kevin M. | EVP, Chief Medical Officer | 27916 0.0032% | $309,867.60 | 0 | 1 | |
| FOOTE WILLIAM C | director | 8207 0.0009% | $91,097.70 | 0 | 11 | |
| JARRETT VALERIE B | director | 4456 0.0005% | $49,461.60 | 1 | 0 | <0.0001% |
| SCHAEFFER LEONARD D | director | 1512 0.0002% | $16,783.20 | 1 | 0 | <0.0001% |
| GRAHAM GINGER L | director | 2150 0.0002% | $23,865.00 | 1 | 0 | +4.11% |
| Babiak Janice M. | director | 1200 0.0001% | $13,320.00 | 2 | 0 | +2.21% |
| Murphy Ken | EVP, Chief Commercial Officer | 653 0.0001% | $7,248.30 | 0 | 1 | |
| SCHLICHTING NANCY M | director | 0 0% | $0 | 0 | 4 | |
| Scardino Kimberly R | SVP, Global Controller and CAO | 0 0% | $0 | 0 | 1 |
WBA Institutional Investors: Active Positions
| Increased Positions | 438 | +41.05% | 71M | +13.74% |
| Decreased Positions | 466 | -43.67% | 54M | -10.37% |
| New Positions | 143 | New | 14M | New |
| Sold Out Positions | 148 | Sold Out | 14M | Sold Out |
| Total Postitions | 1,039 | -2.62% | 536M | +3.36% |
WBA Ownership Change vs Market
Institutional Investor Ownership
| Vanguard Group Inc | $969,543.00 | 9.98% | 86.34M | +2M | +2.71% | 2024-12-31 |
| Blackrock, Inc. | $817,877.00 | 8.42% | 72.83M | +2M | +3% | 2024-12-31 |
| State Street Corp | $483,477.00 | 4.98% | 43.05M | +54,702 | +0.13% | 2024-12-31 |
| Invesco Ltd. | $365,790.00 | 3.77% | 32.57M | +3M | +8.79% | 2024-12-31 |
| Geode Capital Management, Llc | $233,351.00 | 2.4% | 20.78M | +1M | +5.17% | 2024-12-31 |
| Morgan Stanley | $164,885.00 | 1.7% | 14.68M | +511,004 | +3.61% | 2024-12-31 |
| Ubs Group Ag | $152,863.00 | 1.57% | 13.61M | +11M | +374.96% | 2024-12-31 |
| Charles Schwab Investment Management Inc | $147,732.00 | 1.52% | 13.16M | +2M | +19.93% | 2024-12-31 |
| Goldman Sachs Group Inc | $131,152.00 | 1.35% | 11.68M | +4M | +44.6% | 2024-12-31 |
| Northern Trust Corp | $99,910.00 | 1.03% | 8.9M | +1M | +18.8% | 2024-12-31 |